Abstract:Adipogenesis is tightly regulated by various factors, including genes and microRNAs. Excessive fat deposition is the key feature of obesity, which is a low-grade chronic inflammatory disease. Follistatin-like 1 (FSTL1) has been reported to be an important mediator involved in various inflammatory diseases. However, the underlying mechanism of FSTL1 in preadipocyte differentiation and inflammatory response is still unclear. The current study was designed to explore the biological function and potential mechanism of FSTL1 in mouse subcutaneous preadipocyte differentiation. We found that FSTL1 was highly expressed in the early stage of differentiation and subsequently decreased sharply, suggesting that FSTL1 played a possible role in adipogenesis. Meanwhile, the gain-and loss-of- function assays showed that FSTL1 was not only involved in the inflammatory response by inducing the expression of pro-inflammatory factors IL-1 beta and CCL2 but also significantly attenuated preadipocyte differentiation, as evidenced by the reduction of lipid accumulation and the levels of adipogenic genes, including PPAR. and FABP4. In addition, the target gene prediction and luciferase reporter assay validated that miR-125a- 3p targeted the 3' UTR region of FSTL1. These results demonstrated that miR-125a- 3p negatively regulated the expression of FSTL1 at the mRNA and protein levels. Furthermore, overexpressing miR-125a3p in preadipocytes dramatically accelerated adipogenic differentiation and downregulated the levels of IL-1 beta and CCL2, which were in accordance with the knockdown of FSTL1. On the contrary, treatment with miR-125a- 3p inhibitors attenuated adipogenesis but induced the expression of inflammatory genes. In summary, this study suggests a positive function of FSTL1 in adipocyte-induced inflammation and negatively regulates preadipocyte differentiation. Further studies demonstrated that miR-125a- 3p could reverse the effect by targeting FSTL1, which might provide a better understanding of treating obesity-related inflammatory diseases.

MiR-455 Enhances Adipogenic Differentiation of 3T3-L1 Cells Through Targeting Uncoupling Protein-1.

MicroRNA-24 promotes 3T3-L1 adipocyte differentiation by directly targeting the MAPK7 signaling.

MiR-196b-3p and Mir-450B-3p Are Key Regulators of Adipogenesis in Porcine Intramuscular and Subcutaneous Adipocytes.

Mir-10B-5p Regulates 3T3-L1 Cells Differentiation by Targeting Apol6.

Mir-133A Regulates Adipocyte Browning in Vivo.

MicroRNA-125a-5p Mediates 3T3-L1 Preadipocyte Proliferation and Differentiation

MicroRNA-214-3p Targeting Ctnnb1 Promotes 3T3-L1 Preadipocyte Differentiation by Interfering with the Wnt/β-Catenin Signaling Pathway

MiR-378a-3p Enhances Adipogenesis by Targeting Mitogen-Activated Protein Kinase 1.

Mir-143 Enhances Adipogenic Differentiation of 3T3-L1 Cells Through Targeting the Coding Region of Mouse Pleiotrophin

miR-125a-3p regulates the expression of FSTL1, a pro-inflammatory factor, during adipogenic differentiation, and inhibits adipogenesis in mice

miR-370-3p Regulates Adipogenesis through Targeting Mknk1

Curcumin represses mouse 3T3-L1 cell adipogenic differentiation via inhibiting miR-17-5p and stimulating the Wnt signalling pathway effector Tcf7l2

miR-128-3p regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2

Plant miR167e-5p promotes 3T3-L1 adipocyte adipogenesis by targeting β-catenin

miR‐324‐5p promotes adipocyte differentiation and lipid droplet accumulation by targeting Krueppel‐like factor 3 (KLF3)

miR-103 promotes 3T3-L1 cell adipogenesis through AKT/mTOR signal pathway with its target being MEF2D

Mir-199A-3p Regulates Brown Adipocyte Differentiation Through Mtor Signaling Pathway

ssc-miR-451 Regulates Porcine Primary Adipocyte Differentiation by Targeting ACACA

LncRNA MIR99AHG enhances adipocyte differentiation by targeting miR-29b-3p to upregulate PPARγ

Up-regulated miR-199a-3p and miR-126-3p promote adipocyte differentiation by targeting HIF-1α

MiR-335, an Adipogenesis-Related MicroRNA, is Involved in Adipose Tissue Inflammation